Evonik Shares Gain Momentum as Technical and Fundamental Factors Align

Evonik shares hit a 6-month high, breaking key technical resistance. The rally is supported by a confirmed €1.7-2.0B EBITDA outlook and a near 6% dividend yield.

Shares in the specialty chemicals group Evonik are demonstrating renewed strength, buoyed by a combination of robust technical performance and solid underlying financial guidance. The company's strategic pivot toward high-margin specialty products appears to be resonating with investors, distinguishing its equity from that of basic chemical producers.

Technical Breakthrough Signals Strength

A significant technical development has captured market attention. The stock price recently broke decisively above its 200-day moving average, a key benchmark watched by analysts. This line currently sits at €14.86. The move occurred as the share price reached a six-month high of €16.82 on Tuesday, marking a substantial recovery of approximately 26% from its January low of €12.63. The upward move has been accompanied by strong trading activity, with daily volumes on the Xetra platform recently exceeding three million shares, lending credibility to the breakout.

Financial Backbone Provides Support

This positive chart action is underpinned by concrete financial targets. Management has confirmed its full-year outlook, projecting adjusted EBITDA to land between €1.7 billion and €2.0 billion. For income-focused investors, the stock offers a compelling yield. The proposed dividend of €1.00 per share translates to an attractive yield of nearly 6%. This payout also initiates a revised distribution policy, whereby the company intends to return 40% to 60% of its adjusted net income to shareholders going forward. The company's cash conversion rate, reported to be at the upper end of its target range, further supports the sustainability of this financial framework.

Key Dates for the Investor Calendar

The sustainability of the current positive trend will be tested against upcoming financial events. Two critical dates are on the horizon:

• 08 May 2026: Publication of first-quarter financial results.
• 03 June 2026: Annual General Meeting, featuring a vote on the proposed dividend.

The Q1 figures in May will provide the first concrete evidence regarding the company's ability to meet its annual targets. From a technical perspective, analysts suggest that as long as the share price maintains support above the 50-day moving average (approximately €14.55), the constructive near-term outlook for the Essen-based firm remains intact.